Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2007
11/29/2007WO2007136860A1 Alginate modified with synthetic, biocompatible polymers
11/29/2007WO2007136797A1 Methods for diagnosis and prognosis of psychotic disorders
11/29/2007WO2007136752A2 Erythropoietin compositions
11/29/2007WO2007136641A2 Methods of treating acute blood loss anemia with a cross-linked hemoglobin blood substitute
11/29/2007WO2007136635A1 Enhancement of radiation therapy and/or chemotherapy with acid ceramidase modulators
11/29/2007WO2007136555A2 Multifunctional blood substitute
11/29/2007WO2007136294A1 Peptide substance enhancing capillaries resistance, pharmaceutical composition on its base and method of its application
11/29/2007WO2007136157A1 Compositions and methods for treating motor neuron diseases
11/29/2007WO2007136155A1 Methods and compositions for treating motor neuron diseases comprising erythropoietin
11/29/2007WO2007136042A1 Ameliorating agent for brain damage
11/29/2007WO2007135801A1 MICROORGANISM CAPABLE OF PRODUCING γ-L-PGA, METHOD FOR PRODUCTION OF γ-L-PGA USING THE MICROORGANISM, CROSSLINKED PRODUCT, AND AGENT FOR EXTERNAL APPLICATION TO THE SKIN
11/29/2007WO2007135781A1 Peptide capable of enhancing the activity of ephrin-b2, salt thereof, composition for medical purposes, kit for therapy
11/29/2007WO2007135401A2 Method for producing regulatory t cells by costimulating cd55 and cd3
11/29/2007WO2007135390A1 Prevention of plaque formation
11/29/2007WO2007135220A1 Use of proinsulin for the preparation of a neuroprotective pharmaceutical composition, therapeutic composition containing it and applications thereof
11/29/2007WO2007135182A2 Factor ix analogues having prolonged in vivo half life
11/29/2007WO2007135172A2 Cladribine regimen for treating multiple sclerosis
11/29/2007WO2007135118A1 Soluble, stable insulin-containing formulations
11/29/2007WO2007135117A2 Soluble, stable insulin-containing formulations
11/29/2007WO2007134908A2 Use of thymosin alpha 1 for the treatment of immunological diseases
11/29/2007WO2007134906A1 Interferon-beta gene therapy using an improved, regulated expression system
11/29/2007WO2007134813A2 Use of desmodus salivary plasminogen activator (dspa) for treating venous thromboembolism
11/29/2007WO2007134800A1 Ethanol dependence of alpha1 antitrypsin c-terminal lys truncation by basic carboxypeptidases
11/29/2007WO2007134617A1 Use of desmodus salivary plasminogen activator (dspa) for treating venous thromboembolism
11/29/2007WO2007134419A1 Composite preparation process on a basis of bioceramics and biodegradable or non biodegradable polymers, cementing and/or carrier substances containing encapsulated or non-encapsulated micro or nanoparticulated antibiotics and angiostensin (1-7) for tissue restitution and products therefrom
11/29/2007WO2007118901A3 Tracheal cytotoxin (tct) and related compounds for suppressing immune responses
11/29/2007WO2007113365B1 Dairy-protein-derived peptides with angiotensin 1 converting enzyme inhibitory activity
11/29/2007WO2007112345A3 Use of cyclosporin alkene analogues for preventing or treating viral-induced disorders
11/29/2007WO2007112107A3 Synthetic lipid rafts and methods of use
11/29/2007WO2007111931A3 Compositions and methods relating to modulation of immune system components
11/29/2007WO2007109823A3 Peptide library
11/29/2007WO2007101179A3 Enterostatin as therapeutic agent for hypoglycemia
11/29/2007WO2007100248A3 Adir related polymorphisms and applications thereof
11/29/2007WO2007090087A3 Use of corticotropin releasing factor receptor-2 inhibitors for treating insulin-related diseases
11/29/2007WO2007089670A3 Enterically coated cysteamine, cystamine and derivatives thereof
11/29/2007WO2007087415A3 Compositions and methods for inhibition leukocyte function
11/29/2007WO2007084858A3 Biomimetic hydroxyapatite synthesis
11/29/2007WO2007084527A3 Proteins containing a fluorinated amino acid, and methods of using same
11/29/2007WO2007073509A3 Modified annexin proteins and methods for their use in organ transplantation
11/29/2007WO2007068985A3 Diagnosis and prognosis of colorectal cancer
11/29/2007WO2007059513A3 Compositions and methods for modulating hemostasis
11/29/2007WO2007052326A3 Method for conversion of uric acid to allantoin and related enzymes
11/29/2007WO2007052172A3 Methods for fusion polypeptide delivery into a cell
11/29/2007WO2007039606A3 Insulin receptor antagonists and related compositions, uses and methods
11/29/2007WO2007034465A3 Use of il-1f5 for the modulation of an immune-mediated response
11/29/2007WO2007030519A3 Stabilized glp-1 analogs
11/29/2007WO2007024899A3 Use of glp-1, glp-1 derivatives or glp-1 fragments for skin regeneration, stimulation of hair growth, or treatment of diabetes
11/29/2007WO2006133955A8 Adamts13-comprising compositions having thrombolytic activity
11/29/2007WO2005044196A3 Novel modulators of amyloid-beta production and uses thereof
11/29/2007WO2004106361A3 Peptides for metal ion affinity chromatogrpahy
11/29/2007WO2004066958A3 Caspase-9:bir3 domain of xiap complexes and methods of use
11/29/2007WO2004037202A3 Gb virus c and methods of treating viral infections
11/29/2007WO2004015086A3 Enhancement of adenoviral oncolytic activity in prostate cells by modification of the e1a gene product
11/29/2007US20070276129 Modular molecular clasps and uses thereof
11/29/2007US20070276128 Stabilized Proteins with Engineered Disulfide Bonds
11/29/2007US20070276125 Methods for inhibiting immune complex formation in a subject
11/29/2007US20070276040 Peptidyl Arginine Deiminase Type IV Inhibitor
11/29/2007US20070275983 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
11/29/2007US20070275917 Rna Capable of Suppressing Expression of Klf5 Gene
11/29/2007US20070275912 Nucleoside derivatives as inhibitors of rna-dependent RNA viral polymerase
11/29/2007US20070275911 Targeted Drug-Formaldehyde Conjugates and Methods of Making and Using the Same
11/29/2007US20070275906 Compounds and Compositions as Channel Activating Protease Inhibitors
11/29/2007US20070275905 Salts of trimebutine and n-desmethyl trimebutine
11/29/2007US20070275904 Conjugates of aziridinyl-epothilone analogs and pharmaceutical compositions comprising same
11/29/2007US20070275903 oligopeptide conjugates; cleavable by trouase such as Thimet oligopeptidase; antitumor agents
11/29/2007US20070275902 Treatment of Phosphatidylinositol Phospholipid Disorders
11/29/2007US20070275901 Synthesis, modification and reduction of primary structure of hypotensive peptides present in scorpion venom for optimizing their use as a hypotensive medicament
11/29/2007US20070275900 HIV protease inhibitory compounds with ameliorated solubility and/or bioavailability; conjugates of therapeutic compound and a peptide wherein the conjugate is cleavable by dipeptidyl-peptidases
11/29/2007US20070275899 Treatment Of Demyelinating Autoimmune Disease with Modified Ordered Peptides
11/29/2007US20070275898 processivity clamp factor of DNA polymerase and a peptide comprising all or part of the processivity clamp factor binding sequence of a processivity clamp factor interacting protein; uses, in particular for the screening, the design or the modification of ligands
11/29/2007US20070275897 Collagen mimics
11/29/2007US20070275896 Use of Polypeptides in Treating Tissue Injury
11/29/2007US20070275895 Inhibiting proliferation of immune cells in leukemia comprising administering an antibody that specifically binds a follistatin-3 polypeptide; inhibiting B cell or T cell proliferation
11/29/2007US20070275894 Modulators of the ABC Transporter Family and Methods for Their Use
11/29/2007US20070275893 Compositions for enhanced epithelial permeation of peptide yy for treating obesity
11/29/2007US20070275892 Modulating stroma-cell-derived-factor (SDF-1) receptor activity in hematopoietic stem cells, hematopoietic progenitor cells, primitive granulocytes, primitive erythroid cells, leukocytes, and neutrophils; reducing ability to act as substrate to amino/carboxypeptidases
11/29/2007US20070275891 OBG3 globular head and uses thereof
11/29/2007US20070275890 Chaperonin 10 Modulation Of Toll-Like Receptor-Inducible Cytokine And Chemokine Secretion
11/29/2007US20070275889 Gene Expression Technique
11/29/2007US20070275888 Preventive/Remedy for Cancer
11/29/2007US20070275887 Method of Inhibiting Secretase Activity
11/29/2007US20070275886 Phalloidin derivatives and methods for their synthesis
11/29/2007US20070275885 Microcystins as agents for treatment of cancer
11/29/2007US20070275884 Use of modified cyclosporins for the treatment of hcv disorders
11/29/2007US20070275882 Nature-Identical Erythropoietin
11/29/2007US20070275881 Oligosaccharide Compositions and Use Thereof in the Treatment of Infection
11/29/2007US20070275880 Virally-Safe Factor VIII with a Low Content of Higher Multimers
11/29/2007US20070275879 Use of Ulinastatin and Its Pharmaceutical Composition for Treating Severe Acute Respiratory Syndrome
11/29/2007US20070275878 No-modified hemoglobins and uses therefor
11/29/2007US20070275877 Methods for Treating or Ameliorating Ghrelin-Associated Diseases and Disorders
11/29/2007US20070275876 administering a membrane permeable thiol in the form thiol itself or in the form of said membrane permeable thiol disulfide bonded to protein that metabolizes in vivo to produce membrane permeable thiol, reduces extracellular cystine and is concurrently oxidized to a disulfide; cancer, diabetes, AIDS etc
11/29/2007US20070275875 Method for preventing colon cancer
11/29/2007US20070275874 Use of Leptin in Wound Healing
11/29/2007US20070275872 Peptides with Anti-Obesity Activity and Other Related Uses
11/29/2007US20070275871 Epo Mimetic Peptides and Fusion Proteins
11/29/2007US20070275440 Regulation of transcription factor, nf-il6/lap
11/29/2007US20070275437 Antibodies to G protein-coupled receptor
11/29/2007US20070275420 Method For Detecting Prognosis Of Cancer
11/29/2007US20070275401 USE OF Mx GTPASES IN THE PROGNOSIS AND TREATMENT OF CANCER
11/29/2007US20070275391 Novel g-protein coupled receptors and dna sequences thereof
1 ... 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 ... 3163